Duquesne Family Office LLC / BMRN
Duquesne Family Office LLC’s Biomarin Pharmaceutical Inc Position
Does Duquesne Family Office LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 192.7K shares worth $17M in Q4 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$17M
Q4 2020
Shares
192.7K
% of Portfolio
+0.46%
Quarters Held
3
position exited
Position History BMRN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of BMRN.